Desloratadine Market Emerging Trends, Demand, Growth by Key Players and Forecast 2028

Market Overview: The global desloratadine market exhibited significant strength in 2020 and is anticipated to maintain a steady revenue growth rate throughout the forecast period. Key drivers of global desloratadine market revenue include the increasing prevalence of conditions such as nasal congestion, allergic rhinitis, and the broad range of applications for this product in alleviating various allergy symptoms, including itchy and watery noses, runny noses, sneezing, and the management of chronic hives.

Asia Pacific Leads in Revenue CAGR: The Asia Pacific market is projected to achieve the highest revenue growth rate during the forecast period. This is driven by a growing number of patients with chronic idiopathic urticarial, the increasing use of desloratadine in maintenance therapy or as a monotherapy, and the presence of numerous players operating in the region, along with a focus on innovation and advancement.

Major Drivers of Global Desloratadine Market Growth: The robust growth of the global market is driven by a rising global population suffering from allergic rhinitis and nasal congestion, an increasing incidence of chronic diseases, and the demand for innovative pharmaceutical solutions. Additionally, the market benefits from advancements in technology and drug approvals, as well as government and healthcare organizations’ efforts to raise awareness about the disease and available treatments. Moreover, the growing elderly population worldwide and a high prevalence of allergies among the elderly, particularly in developing countries, contribute significantly to revenue growth.

Get a sample copy of the Desloratadine Market report:

Desloratadine, a medication used to relieve allergic symptoms like sneezing, runny nose, and rashes resulting from ongoing allergic reactions, is particularly beneficial in addressing allergic rhinitis, commonly known as hay fever. This condition stems from an immune system overreaction to environmental allergens like pollen, dust, pet dander, or airborne mold. Nasal congestion, a blockage of nasal passages causing discomfort, is also mitigated by desloratadine, which operates by inhibiting the release of histamine during allergic reactions.

Factors Constraining Global Desloratadine Market Growth: Challenges to market growth include low adoption rates due to potential gastrointestinal disturbances, as well as side effects such as fatigue, dry mouth, headache, and vomiting. Furthermore, the lack of a predefined regulatory framework may limit the demand and adoption of desloratadine, somewhat impeding market expansion.

Major Companies Profiled in the Report:

  • Pfizer
  • Teva
  • Novartis
  • Mylan
  • Sumitomo Dainippon
  • Takeda
  • GlaxoSmithKline
  • Mayne Pharma
  • Abbott
  • Schering-Plough

Opportunities for Participants in the Global Desloratadine Market: The use of desloratadine for acne treatment holds potential revenue opportunities for major players in the global desloratadine market. Additionally, an increasing number of mergers, acquisitions, partnerships, and collaborations between international and domestic companies to expand their customer base and production capacity is another avenue for market participants to explore.

Global Desloratadine Market Revenue by Product Type: In 2020, the desloratadine injection segment accounted for the largest share in the global market. The freeze-dried powdered form segment is expected to experience significant revenue growth throughout the forecast period.

North America Dominates Global Desloratadine Market Revenue: In 2020, North America held the largest share of global market revenue and is expected to maintain strong growth throughout the forecast period. The region’s leadership is due to the increasing number of allergic rhinitis patients and the use of desloratadine to treat skin hives and itching in patients with chronic skin reactions.

Strategies and Objectives of Major Companies: In June 2017, Abbott Laboratories acquired St. Jude Medical, a move aimed at driving revenue growth opportunities and advancing research and development efforts in diagnostics, devices, nutritionals, and branded generic pharmaceuticals.

In February 2020, Apollo Pharmaceuticals acquired Covis Pharma, aligning with both companies’ vision to expand respiratory care, global presence, and establish new therapeutic franchises.

Detailed Segmentation in the Report: For this report, the global desloratadine market is segmented based on product type, end-use, and region:

Product Type Outlook (Revenue, USD Billion; 2018-2028)

  • Injection
  • Freeze-dried Powder

End-use Outlook (Revenue, USD Billion; 2018-2028)

  • Hospitals
  • Clinics
  • Others

Region Outlook (Revenue, USD Billion; 2018-2028)

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Benelux
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of Middle East & Africa

Explore Trending Reports:

Dimethylformamide (DMF) Market-

Optical Brighteners Market-

High-Temperature Coatings Market-

Composites Market-

Request a customization of the report:

Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.

About Reports and Data    

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

(Head of Business Development)

Reports and Data | Web:

Direct Line: +1-212-710-1370

E-mail: [email protected]

Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @

Browse More Latest Reports @

Browse Latest Blogs:


Browse Latest Press Release:

Previous post Mobile App Development Companies Redefining Noida
Next post Navigating Success: A Guide to CAIIB Exam Preparation